Moteur de recherche d’entreprises européennes
Financement de l’UE (3 995 643 €) : Technologies à base d’ARN pour l’analyse des métabolites unicellulaires Hor01/01/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Technologies à base d’ARN pour l’analyse des métabolites unicellulaires
Metabolism is the foundation of all living organisms. While cells in a population are often phenotypically different, most of our current analytical approaches still probe metabolism only at the population level. Because strong evidence exists that metabolic cell-to-cell heterogeneity has, for instance, disease relevance, researcher from MetaRNA will overcome this severe analytical limitation through exploiting exciting opportunities emerging from the RNA field. Such synergy potential between the metabolism and RNA research fields has until today not been exploited, because they are separated from each other in Europe and worldwide. Through consequently missing research training programs we thus lack experts with combined knowledge in metabolism and RNA. The aim of the MetaRNA proposal is therefore to establish a European Training Network (ETN) that educates specialists for academia and industry - fully trained at the interface of these two fields - in the development and application of RNA-based sensors to investigate metabolism at the single-cell level, to apply these tools for novel biotechnological applications and to provide a framework for their future use in diagnostics and therapeutics. In MetaRNA, eight research groups from the metabolic and RNA fields and six partners from the private sector join forces to create a platform of mobility and training to 15 early-stage researchers (ESRs), by means of customized research projects, exchange of knowhow among researchers and partners, attendance to specialized courses, workshops and conferences, as well as training in complementary skills.
| APTAIT GmbH | ? |
| Biosyntia ApS | 290 082 € |
| DSM Food Specialties B.V. | 255 374 € |
| Danmarks Tekniske Universitet | 580 164 € |
| Institut National de la Sante et de la Recherche Medicale | 525 751 € |
| Kobenhavns Universitet | 290 082 € |
| RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN | 498 433 € |
| Rijksuniversiteit Groningen | 510 749 € |
| TECHNISCHE UNIVERSITAT DARMSTADT | 498 433 € |
| The Francis Crick Institute Ltd. | 250 514 € |
| United Kingdom Research and Innovation | 22 774 € |
| University of Warwick | 273 288 € |
https://cordis.europa.eu/project/id/642738
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : BioNTech Real Estate Holding GmbH, Mainz, Allemagne.
Les visualisations de "APTAIT GmbH - Financement de l’UE (3 995 643 €) : Technologies à base d’ARN pour l’analyse des métabolites unicellulaires"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
